Zizyphoiside C
Internal ID | 54f8390a-4f38-4194-80b5-a481757c071b |
Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Triterpenoids |
IUPAC Name | [2-[2-[3,5-dihydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl] acetate |
SMILES (Canonical) | CC1C(C(C(C(O1)OC2C(C(OC(C2O)OC3C(COC(C3O)OC4CCC5(C6CCC7C8C(CC(OC89CC7(C6(CCC5C4(C)C)C)CO9)C=C(C)C)(C)O)C)O)CO)O)O)OC(=O)C)O |
SMILES (Isomeric) | CC1C(C(C(C(O1)OC2C(C(OC(C2O)OC3C(COC(C3O)OC4CCC5(C6CCC7C8C(CC(OC89CC7(C6(CCC5C4(C)C)C)CO9)C=C(C)C)(C)O)C)O)CO)O)O)OC(=O)C)O |
InChI | InChI=1S/C49H78O18/c1-22(2)16-25-17-47(9,58)40-26-10-11-30-45(7)14-13-31(44(5,6)29(45)12-15-46(30,8)48(26)20-49(40,67-25)60-21-48)64-41-34(55)37(27(52)19-59-41)65-43-36(57)39(33(54)28(18-50)63-43)66-42-35(56)38(62-24(4)51)32(53)23(3)61-42/h16,23,25-43,50,52-58H,10-15,17-21H2,1-9H3 |
InChI Key | DPKBVIDMZOJSPB-UHFFFAOYSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C49H78O18 |
Molecular Weight | 955.10 g/mol |
Exact Mass | 954.51881563 g/mol |
Topological Polar Surface Area (TPSA) | 262.00 Ų |
XlogP | 2.60 |
Atomic LogP (AlogP) | 1.57 |
H-Bond Acceptor | 18 |
H-Bond Donor | 8 |
Rotatable Bonds | 9 |
156408-67-2 |
DTXSID30935437 |
20-hydroxy-16,23:16,30-diepoxydammar-24-en-3-yl 3-o-acetyl-6-deoxyhexopyranosyl-(1->3)hexopyranosyl-(1->3)pentopyranoside |
3-O-Acetylrhamnopyranosyl-1-3-glucopyranosyl-1-3-arabinopyraosyl-1-3-jujubogenin |
[2-[2-[3,5-dihydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl] acetate |
alpha-L-Arabinopyranoside, (3beta,16beta,23R)-16,23:16,13-diepoxy-20-hydroxydammar-24-en-3-yl O-3-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1-3)-O-beta-D-glucopyranosyl-(1-3)- |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8976 | 89.76% |
Caco-2 | - | 0.8816 | 88.16% |
Blood Brain Barrier | - | 0.5250 | 52.50% |
Human oral bioavailability | - | 0.7714 | 77.14% |
Subcellular localzation | Mitochondria | 0.8092 | 80.92% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8025 | 80.25% |
OATP1B3 inhibitior | + | 0.8763 | 87.63% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 0.7000 | 70.00% |
BSEP inhibitior | + | 0.8874 | 88.74% |
P-glycoprotein inhibitior | + | 0.7505 | 75.05% |
P-glycoprotein substrate | + | 0.6396 | 63.96% |
CYP3A4 substrate | + | 0.7563 | 75.63% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8806 | 88.06% |
CYP3A4 inhibition | - | 0.8791 | 87.91% |
CYP2C9 inhibition | - | 0.8531 | 85.31% |
CYP2C19 inhibition | - | 0.9084 | 90.84% |
CYP2D6 inhibition | - | 0.9287 | 92.87% |
CYP1A2 inhibition | - | 0.9133 | 91.33% |
CYP2C8 inhibition | + | 0.7407 | 74.07% |
CYP inhibitory promiscuity | - | 0.8860 | 88.60% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5543 | 55.43% |
Eye corrosion | - | 0.9909 | 99.09% |
Eye irritation | - | 0.9052 | 90.52% |
Skin irritation | - | 0.5272 | 52.72% |
Skin corrosion | - | 0.9452 | 94.52% |
Ames mutagenesis | - | 0.5200 | 52.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8068 | 80.68% |
Micronuclear | - | 0.8800 | 88.00% |
Hepatotoxicity | - | 0.8000 | 80.00% |
skin sensitisation | - | 0.9032 | 90.32% |
Respiratory toxicity | + | 0.6667 | 66.67% |
Reproductive toxicity | + | 0.8778 | 87.78% |
Mitochondrial toxicity | - | 0.5125 | 51.25% |
Nephrotoxicity | - | 0.8420 | 84.20% |
Acute Oral Toxicity (c) | I | 0.5311 | 53.11% |
Estrogen receptor binding | + | 0.8261 | 82.61% |
Androgen receptor binding | + | 0.7532 | 75.32% |
Thyroid receptor binding | + | 0.5241 | 52.41% |
Glucocorticoid receptor binding | + | 0.7451 | 74.51% |
Aromatase binding | + | 0.6509 | 65.09% |
PPAR gamma | + | 0.8283 | 82.83% |
Honey bee toxicity | - | 0.5785 | 57.85% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | + | 0.5445 | 54.45% |
Fish aquatic toxicity | + | 0.9455 | 94.55% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.98% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.60% | 91.11% |
CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 94.32% | 91.24% |
CHEMBL2581 | P07339 | Cathepsin D | 93.62% | 98.95% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 92.46% | 95.93% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.30% | 96.61% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 91.88% | 89.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 90.90% | 94.45% |
CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 90.64% | 95.36% |
CHEMBL325 | Q13547 | Histone deacetylase 1 | 90.12% | 95.92% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.78% | 91.19% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 89.33% | 95.56% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 89.18% | 86.33% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.09% | 100.00% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.08% | 97.25% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 88.88% | 98.75% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 88.86% | 95.89% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 88.59% | 94.75% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 87.16% | 95.50% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 85.99% | 97.28% |
CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 85.24% | 97.47% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.09% | 97.09% |
CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 84.00% | 89.44% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 83.89% | 92.62% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 83.63% | 92.50% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 83.48% | 92.94% |
CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 83.45% | 89.67% |
CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 | 83.42% | 95.52% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 82.93% | 95.71% |
CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.78% | 94.33% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 82.33% | 100.00% |
CHEMBL5028 | O14672 | ADAM10 | 81.89% | 97.50% |
CHEMBL1907601 | P11802 | Cyclin-dependent kinase 4/cyclin D1 | 81.72% | 98.99% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 81.40% | 89.05% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.18% | 95.89% |
CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 81.14% | 91.07% |
CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 81.01% | 95.71% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.48% | 82.69% |
CHEMBL5555 | O00767 | Acyl-CoA desaturase | 80.33% | 97.50% |
CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 80.29% | 97.86% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 80.06% | 99.17% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.03% | 89.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Alphitonia zizyphoides |
PubChem | 190837 |
LOTUS | LTS0264785 |
wikiData | Q82911482 |